ATE519764T1 - Spiroindolinon-derivate - Google Patents

Spiroindolinon-derivate

Info

Publication number
ATE519764T1
ATE519764T1 AT08861848T AT08861848T ATE519764T1 AT E519764 T1 ATE519764 T1 AT E519764T1 AT 08861848 T AT08861848 T AT 08861848T AT 08861848 T AT08861848 T AT 08861848T AT E519764 T1 ATE519764 T1 AT E519764T1
Authority
AT
Austria
Prior art keywords
spiroindolinone derivatives
spiroindolinone
derivatives
compounds
esters
Prior art date
Application number
AT08861848T
Other languages
English (en)
Inventor
Qingjie Ding
Nan Jiang
Song Yang
Jing Zhang
Zhuming Zhang
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE519764T1 publication Critical patent/ATE519764T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT08861848T 2007-12-14 2008-12-05 Spiroindolinon-derivate ATE519764T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1369107P 2007-12-14 2007-12-14
US10743108P 2008-10-22 2008-10-22
PCT/EP2008/066874 WO2009077357A1 (en) 2007-12-14 2008-12-05 Spiroindolinone derivatives

Publications (1)

Publication Number Publication Date
ATE519764T1 true ATE519764T1 (de) 2011-08-15

Family

ID=40289301

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08861848T ATE519764T1 (de) 2007-12-14 2008-12-05 Spiroindolinon-derivate

Country Status (12)

Country Link
US (1) US8134001B2 (de)
EP (1) EP2229396B1 (de)
JP (1) JP2011506380A (de)
KR (1) KR20100076037A (de)
CN (1) CN101896486A (de)
AT (1) ATE519764T1 (de)
AU (1) AU2008337651A1 (de)
BR (1) BRPI0821255A2 (de)
CA (1) CA2707456A1 (de)
IL (1) IL205354A0 (de)
MX (1) MX2010006107A (de)
WO (1) WO2009077357A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776875B2 (en) * 2007-12-19 2010-08-17 Hoffman-La Roche Inc. Spiroindolinone derivatives
US8354444B2 (en) * 2008-09-18 2013-01-15 Hoffmann-La Roche Inc. Substituted pyrrolidine-2-carboxamides
KR20120099462A (ko) * 2009-11-12 2012-09-10 더 리젠츠 오브 더 유니버시티 오브 미시건 스피로-옥신돌 mdm2 길항제
US8288431B2 (en) * 2010-02-17 2012-10-16 Hoffmann-La Roche Inc. Substituted spiroindolinones
MX2013005238A (es) 2010-11-12 2013-09-02 Univ Michigan Antagonistas de mdm2 de espiro-oxindol.
CN102584835B (zh) * 2011-01-17 2014-08-27 苏州大学 一种含吲哚结构的螺杂环化合物及其制备方法
DK2684880T3 (en) 2011-03-10 2018-05-22 Daiichi Sankyo Co Ltd DISPIROPYRROLIDINE DERIVATIVES
BR112013028983A2 (pt) 2011-05-11 2017-02-07 Sanofi Sa antagonistas mdm2 espiro-oxindol
CN102321095B (zh) * 2011-05-26 2014-09-10 兰州大学 手性螺环吲哚-吡喃嘧啶碱类化合物及其制备和应用
CA2850166C (en) * 2011-09-27 2019-12-03 Amgen Inc. Heterocyclic compounds as mdm2 inhibitors for the treatment of cancer
CN102627650B (zh) * 2012-03-08 2015-07-08 徐州师范大学 手性四氢吡咯-3,2′-氧化吲哚螺环化合物及其合成方法
TWI586668B (zh) 2012-09-06 2017-06-11 第一三共股份有限公司 二螺吡咯啶衍生物之結晶
EP3036222A2 (de) * 2013-08-23 2016-06-29 Virginia Commonwealth University Esternitratderivate von aromatischen aldehyden mit mehreren pharmalogischen eigenschaften zur behandlung von sichelzellanämie
JP6503386B2 (ja) 2014-07-03 2019-04-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング MDM2−p53阻害剤としての新しいスピロ[3H−インドール−3,2’−ピロリジン]−2(1H)−オン化合物および誘導体
MX373033B (es) 2014-08-21 2020-05-27 Boehringer Ingelheim Int Nuevos compuestos de espiro[3h-indol-3,2´-pirrolidin]-2(1h)-ona y derivados como inhibidores de mdm2-p53.
KR102595395B1 (ko) 2015-02-20 2023-10-27 다이이찌 산쿄 가부시키가이샤 암의 병용 치료법
HK1251165A1 (en) 2015-04-13 2019-01-25 Daiichi Sankyo Company, Limited Treatment method combining mdm2 inhibitor and btk inhibitor
EP3359542B1 (de) 2015-10-09 2021-03-17 Boehringer Ingelheim International GmbH Spiro[3h-indol-3,2´-pyrrolidin]-2(1h)-on-verbindungen und derivate als mdm2-p53-hemmer
CN118436801A (zh) 2016-05-20 2024-08-06 豪夫迈·罗氏有限公司 Protac抗体缀合物及其使用方法
TW201818934A (zh) 2016-10-17 2018-06-01 日商第一三共股份有限公司 Mdm2抑制劑與dna甲基轉移酶抑制劑之倂用治療法
CN113543852A (zh) 2019-03-06 2021-10-22 第一三共株式会社 吡咯并吡唑衍生物
WO2023056069A1 (en) 2021-09-30 2023-04-06 Angiex, Inc. Degrader-antibody conjugates and methods of using same
CN116253736B (zh) * 2023-01-06 2024-06-18 中山大学 一种吡唑β-内酰胺类衍生物及其制备方法和应用
WO2024240858A1 (en) 2023-05-23 2024-11-28 Valerio Therapeutics Protac molecules directed against dna damage repair system and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7495007B2 (en) * 2006-03-13 2009-02-24 Hoffmann-La Roche Inc. Spiroindolinone derivatives
US20070213341A1 (en) * 2006-03-13 2007-09-13 Li Chen Spiroindolinone derivatives
AU2007224452A1 (en) 2006-03-13 2007-09-20 F. Hoffmann-La Roche Ag Spiroindolinone derivatives
US7638548B2 (en) * 2006-11-09 2009-12-29 Hoffmann-La Roche Inc. Spiroindolinone derivatives

Also Published As

Publication number Publication date
MX2010006107A (es) 2010-06-25
US8134001B2 (en) 2012-03-13
IL205354A0 (en) 2010-12-30
US20090156610A1 (en) 2009-06-18
EP2229396A1 (de) 2010-09-22
BRPI0821255A2 (pt) 2015-06-16
AU2008337651A1 (en) 2009-06-25
JP2011506380A (ja) 2011-03-03
KR20100076037A (ko) 2010-07-05
CA2707456A1 (en) 2009-06-25
EP2229396B1 (de) 2011-08-10
WO2009077357A1 (en) 2009-06-25
CN101896486A (zh) 2010-11-24

Similar Documents

Publication Publication Date Title
ATE519764T1 (de) Spiroindolinon-derivate
DK2235017T3 (da) Spiroindolinonderivater som anticancermidler
ATE495176T1 (de) Spiroindolinon-derivate
MY160424A (en) Substituted pyrrolidine-2-carboxyamides.
CY1119049T1 (el) Υποκατεστημενα πυρρολιδινο-2-καρβοξαμιδια
CR20110684A (es) Derivados de imidazolidin-2-ona 1,3-disustituida como inhibidores de cyp17
TW200801000A (en) Spiroindolinone derivatives
IN2012DN02487A (de)
MX2011008176A (es) Derivados de 3,3'-espiroindolinona como agentes anticancerigenos.
WO2007117465A3 (en) Indazole compounds
WO2007084728A3 (en) 2-imino-benzimidazoles
TW200740758A (en) Benzoquinazoline derivatives
EP2581372A4 (de) Cyanochinolinderivate
MX2009003081A (es) Derivados de pirrola utiles para el tratamiento de enfermedades mediadas por citoquinas.
MX2011007886A (es) Derivado de espiroindolinona piridina.
ATE528290T1 (de) Spiroindolinon-derivate
TNSN08369A1 (en) Benzimidazole derivatives
ATE469647T1 (de) Thienoä3,2-cüpyridin-7-carbonsäure-derivate
MX345264B (es) Derivado de azol.
EA200970692A1 (ru) Способы улучшения стабильности стероидных производных
EA200901085A1 (ru) Производные циклогексиламида арилкарбоновой кислоты
MX2010008778A (es) Derivados de 3-alquil-piperazina y usos de la misma.
UA103497C2 (en) Substituted pyrrolidine-2-carboxamides
CY1113810T1 (el) Υποκατεστημενα πυρρολιδινο-2-καρβοξαμιδια

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties